Document Actions
Following NICE guidelines for diabetes treatment 'could save NHS £625m'
The NHS could have saved a total of £625 million if it had prescribed NICE-recommended drugs for the treatment of type 2 diabetes as opposed to other treatment options, according to a new study.
NICE's guideline on type 2 diabetes recommends that human NPH insulin should be the first-line treatment offered to people with the condition.
However, a study published in BMJ Open, has found that NHS spending on insulin analogues rose from £18.2 million to £305 million between 2000 and 2009.
